Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical Prospects
Cancer Treatment and Research Communications · 2026
DOI: 10.1016/j.ctarc.2026.101155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Usamah Sayed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: u…. Hauptthemen laut MEDLINE: Neoplasms, Interferons, RNA, Untranslated. Die Arbeit nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interferon (IFN) signaling plays a vital role in influencing tumor outcomes, acting as a switch between immune control and evasion based on the situation. When IFN responses are acute and well-regulated, they enhance processes such as antigen processing, dendritic cell activation, cytotoxic lymphocyte response, and the activation of interferon-stimulated genes (ISGs), which lead to cell cycle arrest and programmed cell death. Conversely, prolonged or dysfunctional IFN signaling can be exploited by tumors, resulting in immunoediting, increased checkpoint molecule expression, T-cell exhaustion, stress tolerance, and resistance to therapy and metastasis. The tumor microenvironment (TME) affects this dual role by influencing immune cell infiltration, stromal and blood vessel behavior, and metabolic constraints. Non-coding RNAs (ncRNAs)-including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)-add an extra regulatory layer by modulating IFN induction, JAK-STAT signaling, IRF/STAT-driven gene transcription, and ISG programming. There exists a bidirectional relationship: tumor-suppressive ncRNAs enhance IFN responses and immunogenicity, whereas oncogenic ncRNAs can suppress signaling and facilitate immune escape. The discussion also explores compartment-specific effects within the TME, links to epithelial-mesenchymal transition (EMT) and metastatic plasticity, and the potential of ncRNAs as biomarkers, therapeutic targets, and the challenges in translating these insights into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: u.sayed@ammanu.edu.jo.
- Department of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq. Electronic address: waleedk.abdulsahib@uoalfarahidi.edu.iq.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India. Electronic address: j.renuka@jainuniversity.ac.in.
- Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751003, India. Electronic address: drpriya.sjh@gmail.com.
- Uttaranchal Institute of Pharmaceutical Sciences, Division of research and innovation, Uttaranchal University, Dehradun, Uttarakhand, India. Electronic address: ashishchauhan.pharmacy@gmail.com.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India. Electronic address: siyasingla0202@outlook.com.
Zitieren
APA
Sayed, U., Abdulsahib, W. K., Jyothi, S. R., Nayak, P. P., Chauhan, A. S., Singla, S., Polatova, D., Sead, F. F., & Akhavan-Sigari, R. (2026). Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical Prospects. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101155
Vancouver
Sayed U, Abdulsahib WK, Jyothi SR, Nayak PP, Chauhan AS, Singla S, et al. Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical Prospects. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101155
BibTeX
@article{Sayed2026,
author = {Sayed, Usamah and Abdulsahib, Waleed K and Jyothi, S Renuka and Nayak, Priya Priyadarshini and Chauhan, Ashish Singh and Singla, Siya and Polatova, Djamila and Sead, Fadhil Faez and Akhavan-Sigari, Reza},
title = {Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical Prospects},
journal = {Cancer Treatment and Research Communications},
year = {2026},
doi = {10.1016/j.ctarc.2026.101155}
}
EUVIMED